StartUPDATES: New developments from healthcare startups
Read about news from life science companies Emulate, Astrocyte Pharmaceuticals and Bone Health Technologies.
Organovo cofounder and long-time CEO Keith Murphy steps down
After a decade at the helm, Organovo's Keith Murphy is stepping down, to be replaced by eStudySite's Taylor Crouch. It marks a new era of commercialization for the San Diego company that has long been a pioneer in the 3D bioprinting of tissues and organs.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Emulate and FDA join forces to build a better model
The hope is that the company’s liver chip will predict toxicity in humans better than current cell-based and animal models.
Researchers created a menstrual cycle on a chip, paving the way for innovative cancer research
The research project, spawned by NIH efforts to create a “body-on-a-chip”, led to a lot of firsts, such as new 3D models for uterus and cervix, but it’s the applications that are generating the team’s excitement.
From orthopedics to MS, Ananda Devices wants to harness the potential of organ-on-a-chip
Ananda Devices CEO talks about plans for expanding its organ-on-a-chip tech from researching spinal cord injuries to neurological diseases such as multiple sclerosis.
Organ-on-a-chip startup Emulate raises $28.75M Series B
Emulate wants its technology to "operate as a plug-and-play system in the hands of product development teams at pharmaceutical, chemical, food and consumer products companies," CEO James Coon said in a statement.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.